11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
The United States District Court of Oregon (“Court”) addressed in an April 14th Opinion an action ...
Read More >
The Ballard Spahr Zoning and Land Use Team is continuing to monitor all aspects of the Philadelphia ...
Read More >
Advisors ask me all the time of the role of education in participant-directed 401(k) plans. Particip...
Read More >
P.A.L. Environmental Safety Corp. v. North American Dismantling Corp. Et Al., No. 19-11630, 2020 BL ...
Read More >
2020 is upon us, and with it, a slew of new employment laws that are now in effect. Read on for a de...
Read More >
On June 13, 2019, the Department of Health and Human Services (HHS), the Department of Labor (DOL), ...
Read More >